[01] Aposyretai to AVANDIA

Se anakoinwsh ths yphresias anaferetai oti to AVANDIA "qa stamathsei na diatiqetai sthn Eyrwph mesa stoys epomenoys mhnes".

H apofash elhfqh meta thn apofash twn amerikanikwn ygeionomikwn arxwn na perioristei h prosbash sto sygkekrimeno farmako alla den proxwrhsan sthn kaqolikh apagoreysh toy. Etsi epitrepetai sthn farmakeytikh etairia GlaxoSmithKline na synexisei th diaqesh toy farmakoy sthn amerikanikh agora.

H Epitroph Trofimwn kai Farmakwn (FDA) twn Hnwmenwn Politeiwn anakoinwse oti to farmako qa diatiqetai se neoys asqeneis mono sthn periptwsh poy den mporoyn na elegjoyn to diabhth me alla skeyasmata.

" H FDA pairnei ayth thn prwtoboylia gia na prostatecei toys asqeneis, meta apo prosektikes prospaqeies ektimhshs twn wfelhmatwn kai twn kindynwn", dhlwse h epitropos Margkaret Xampoyrgk.

Einai h deyterh fora mesa se tria xronia poy h FDA apofasizei na parameinei to AVANDIA sthn agora para tis synexws ayjanomenes pieseis toso apo iatrikoys kykloys oso kai apo politikoys gia na aposyrqei to farmako.

H FDA enekrine gia prwth fora thn kykloforia toy farmakoy to 1999 kai egine to prwto farmako se pwlhseis dieqnws gia th ryqmish toy diabhth.

More details on the subscriber's page of APE-MPE | Subscription request form

Athens News Agency: News in ASCII Greek Directory - Previous Article - Next Article